187 related articles for article (PubMed ID: 15557171)
1. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.
You S; Chen C; Lee WH; Brusko T; Atkinson M; Liu CP
J Immunol; 2004 Dec; 173(11):6777-85. PubMed ID: 15557171
[TBL] [Abstract][Full Text] [Related]
2. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
[TBL] [Abstract][Full Text] [Related]
4. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
Quinn A; McInerney MF; Sercarz EE
J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
[TBL] [Abstract][Full Text] [Related]
5. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
[TBL] [Abstract][Full Text] [Related]
6. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
[TBL] [Abstract][Full Text] [Related]
7. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
8. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
Judkowski V; Pinilla C; Schroder K; Tucker L; Sarvetnick N; Wilson DB
J Immunol; 2001 Jan; 166(2):908-17. PubMed ID: 11145667
[TBL] [Abstract][Full Text] [Related]
9. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
10. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
Sévère S; Gauvrit A; Vu AT; Bach JM
Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
[TBL] [Abstract][Full Text] [Related]
12. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
13. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H
J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840
[TBL] [Abstract][Full Text] [Related]
15. Glutamic acid decarboxylase-specific CD4+ regulatory T cells.
Liu CP
Ann N Y Acad Sci; 2006 Oct; 1079():161-70. PubMed ID: 17130549
[TBL] [Abstract][Full Text] [Related]
16. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
[TBL] [Abstract][Full Text] [Related]
17. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.
Zekzer D; Wong FS; Ayalon O; Millet I; Altieri M; Shintani S; Solimena M; Sherwin RS
J Clin Invest; 1998 Jan; 101(1):68-73. PubMed ID: 9421467
[TBL] [Abstract][Full Text] [Related]
18. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
Koarada S; Wu Y; Ridgway WM
J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
[TBL] [Abstract][Full Text] [Related]
19. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice.
Lepault F; Gagnerault MC
J Immunol; 2000 Jan; 164(1):240-7. PubMed ID: 10605017
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]